Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DDAH1 | O94760 | 1/20 | 0.34 |
| ▸ | NSD2 | O96028 | 1/20 | 0.34 |
| ▸ | G6PD | P11413 | 1/20 | 0.34 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.34 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.34 |
| ▸ | PTGS1 | P23219 | 5/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 5/20 | 0.32 |
| ▸ | MGLL | Q99685 | 2/20 | 0.32 |
| ▸ | GSK3A | P49840 | 1/20 | 0.32 |
| ▸ | GSK3B | P49841 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15301140 | 0.78 | TDP1 (0.32) | MGLLGSK3AGSK3B | |
| SCHEMBL12038009 | 0.78 | ALDH1A1 (0.36) | MGLLGSK3AGSK3B | |
| SCHEMBL4463617 | 0.73 | ALDH1A1 (0.39) | MGLLGSK3AGSK3B | |
| SCHEMBL13531991 | 0.73 | GSK3A (0.32) | MGLLGSK3AGSK3B | |
| SCHEMBL9443365 | 0.72 | — | — | |
| SCHEMBL711961 | 0.69 | NSD2 (0.41) | DDAH1NSD2G6PDKEAP1NFE2L2 | |
| SCHEMBL28434369 | 0.69 | GSK3A (0.49) | MGLLGSK3AGSK3B | |
| SCHEMBL10516220 | 0.69 | MGLL (0.35) | MGLLGSK3AGSK3B | |
| SCHEMBL4857568 | 0.69 | MGLL (0.41) | MGLLGSK3AGSK3B | |
| SCHEMBL11050099 | 0.69 | CA12 (0.47) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3849780-B1 | THREE-DIMENSIONAL OBJECT AND MANUFACTURING METHOD THEREOF | ADMATEC EUROPE B V (NL) | 2024-06-12 | — | — | EP | claimed |
| CN-109608379-A | A kind of-two polyethylene glycol of protein cross agent maleimide-acrylic acid succinimide ester preparation method | 苏州昊帆生物股份有限公司 | 2019-04-12 | — | — | CN | claimed |
| EP-1359461-A2 | Low loss electro-optic polymers and devices made therefrom | Corning Incorporated (US) | 2003-11-05 | — | — | EP | claimed |
| US-20030201429-A1 | Low loss electro-optic polymers and devices made therefrom | CORNING INCORPORATED | 2003-10-30 | — | — | US | claimed |
| CN-114806476-A | Epoxy resin conductive adhesive containing composite conductive filler and preparation method thereof | 罗卫中 | 2022-07-29 | — | — | CN | disclosed |
| EP-3221698-B1 | POROUS MEMBRANES WITH A POLYMER GRAFTING, METHODS AND USES THEREOF | Global Life Sciences Solutions Operations UK Ltd (GB) | 2021-02-17 | — | — | EP | disclosed |
| CN-109608379-A | A kind of-two polyethylene glycol of protein cross agent maleimide-acrylic acid succinimide ester preparation method | 苏州昊帆生物股份有限公司 | 2019-04-12 | — | — | CN | disclosed |
| EP-1359461-A2 | Low loss electro-optic polymers and devices made therefrom | Corning Incorporated (US) | 2003-11-05 | — | — | EP | disclosed |
| US-20030201429-A1 | Low loss electro-optic polymers and devices made therefrom | CORNING INCORPORATED | 2003-10-30 | — | — | US | disclosed |
| CN-1295680-A | Photopolymerization compositions including maleimides and processes for using the same | FIRST CHEMICAL CORP (US) | 2001-05-16 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030201429-A1 | Low loss electro-optic polymers and devices made therefrom | PPOX, GALE, ELOVL3 | DDAH1 3786/4885NSD2 4832/4885G6PD 2499/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.